<DOC>
	<DOCNO>NCT00561951</DOCNO>
	<brief_summary>To evaluate efficacy safety fesoterodine comparison placebo overactive bladder .</brief_summary>
	<brief_title>Dose-Finding Study To Evaluate The Efficacy , Tolerability And Safety Of Fesoterodine In Comparison To Placebo For Overactive Bladder .</brief_title>
	<detailed_description />
	<mesh_term>Urinary Bladder , Overactive</mesh_term>
	<mesh_term>Fesoterodine</mesh_term>
	<criteria>Adult OAB patient present OAB symptom , include micturition &gt; = 8 per day urgency urinary incontinence &gt; = 1 per day . Patient known hypersensitivity active substance ( fesoterodine fumarate ) peanut soya excipients . Patient known neurological disease influence bladder function . Patient complication lower urinary tract pathology potentially responsible urgency incontinence , clinically relevant bladder outlet obstruction pelvic organ prolapse .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2011</verification_date>
</DOC>